Product Theater Schedule

October 15 –23
Thursday, October 15
5:15 pm – 6:00 pm ET

Selecting a First-in-Class Oral Therapy for Patients With HR+/HER2- Metastatic Breast Cancer

Desiree Grogan, RPA-C, MSHS
ProHEALTH Care Associates, LLP, Department of Oncology

Patient Ambassador Veronica E.

Pfizer Oncology

Friday, October 16
3:45 pm –4:30 pm ET

Treatment Options for the Management of Certain Patients with First-Line Non-Small Cell Lung Cancer

Nancy Gudex, MSN, ANP-BC, AOCNP
Bristol Myers Squibb, Immuno-Oncology Clinical Liaison

Bristol Myers Squibb

Saturday, October 17
1:30 pm –2:15 pm ET

Pharmacyclics and Janssen Present: The Leukemia & Lymphoma Society Patient Resources: Assisting Blood Cancer Patients and Their Families

Karen Demairo, MHSA, Vice President
Education, Support & Integration

Aaron Kaplowitz, MS, MBA
Janssen Biotech, Inc.

Gigi Bellamy, MSN, RN, OCN
Pharmacyclics LLC, an AbbVie Company

Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

Sunday, October 18
2:00 pm– 2:45 pm ET

Advanced Practice Providers and Their Role in Management of Patients with Bone Metastases

Jacob K. Kettle, PharmD, BCOP


Monday, October 19
11:30 am– 12:15 pm ET

Advancements in the Treatment of Lung Cancer

Melissa Carver, MSN, AOCN, APRN
Florida Cancer Specialists

Genentech, A Member of the Roche Group

Tuesday, October 20
2:00 pm– 2:45 pm ET

Venetoclax AML Patient Management: Practical Guidance for Advanced Practice Oncology Providers

Glen J. Peterson, DNP, ACNP
University of Colorado, Hematological Malignancies and Bone Marrow Transplant Program


Wednesday, October 21
12:30 pm– 1:15 pm ET

Treating Patients with Advanced Prostate Cancer: mCSPC and nmCRPC

Kaylinn Musto, NP
Medical College of Wisconsin, Froedtert Hospital

Janssen Biotech, Inc.

Thursday, October 22
3:45 pm– 4:30 pm ET

CABOMETYX®: Clinical Management of Advanced RCC and HCC

Kimberly Allman, MSN, CNP, OCN
Cleveland Clinic Foundation

Exelixis, Inc.

Friday, October 23
11:45 am– 12:30 pm ET

First Line Ovarian Cancer Maintenance Therapy

Kimberly Halla, FNP
Arizona Oncology Associates


October 26 – November 6
Monday, October 26
1:00 pm – 1:45 pm ET

A treatment regimen for previously treated adults with BRAFmt metastatic colorectal cancer

Shanetia S. Avinger, DNP, MSN, APRN, FNP-C
Cancer Treatment Centers of America, GI Malignancies Team

Pfizer Oncology

Wednesday, October 28
12:45 pm – 1:30 pm ET

Important Treatment Considerations for Patients with Relapsed or Refractory Multiple Myeloma

Patricia A. Mangan, APRN-BC
Abramson Cancer Center, University of Pennsylvania


Friday, October 30
12:45 pm – 1:30 pm ET

CAR T Cell Therapy: The Science and the Patient Journey

Reiko Torgeson, MN, RN, OCN
Bristol Myers Squibb

Carly Borchert, MSN, RN, OCN
Bristol Myers Squibb

Bristol Myers Squibb

Tuesday, November 3
4:00 pm – 4:45 pm ET

Redefining Approaches in Early Line Multiple Myeloma Treatment

Central Arkansas Veterans Healthcare System

Janssen Biotech, Inc.